Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma
Authors
Morschhauser, F.Dyer, M. J. S.
Walter, H. S.
Danilov, A. V.
Ysebaert, L.
Hodson, D. J.
Fegan, C.
Rule, S. A.
Radford, John A
Cartron, G.
Bouabdallah, K.
Davies, A. J.
Spurgeon, S.
Rajakumaraswamy, N.
Li, B.
Humeniuk, R.
Huang, X.
Bhargava, P.
Jürgensmeier, J. M.
Salles, G.
Affiliation
Univ. Lille, CHU Lille, ULR 7365, GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France.Issue Date
2020
Metadata
Show full item recordCitation
Morschhauser F, Dyer MJS, Walter HS, Danilov AV, Ysebaert L, Hodson DJ, et al. Phase 1b study of tirabrutinib in combination with idelalisib or entospletinib in previously treated B-cell lymphoma. Leukemia. 2020.Journal
LeukemiaDOI
10.1038/s41375-020-01108-xPubMed ID
33328591Additional Links
https://dx.doi.org/10.1038/s41375-020-01108-xType
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1038/s41375-020-01108-x
Scopus Count
Collections
Related articles
- Phase Ib Study of Tirabrutinib in Combination with Idelalisib or Entospletinib in Previously Treated Chronic Lymphocytic Leukemia.
- Authors: Danilov AV, Herbaux C, Walter HS, Hillmen P, Rule SA, Kio EA, Karlin L, Dyer MJS, Mitra SS, Yi PC, Humeniuk R, Huang X, Zhou Z, Bhargava P, Jürgensmeier JM, Fegan CD
- Issue date: 2020 Jun 15
- Haematological cancer: idelalisib-targeting PI3Kδ in patients with B-cell malignancies.
- Authors: Burger JA, Okkenhaug K
- Issue date: 2014 Apr
- Efficacy and safety of idelalisib for the treatment of indolent B-cell malignancies.
- Authors: Smolewski P, Rydygier D
- Issue date: 2020 Oct
- Idelalisib for the treatment of non-Hodgkin lymphoma.
- Authors: Graf SA, Gopal AK
- Issue date: 2016
- Idelalisib for chronic lymphocytic leukemia.
- Authors: Brown JR
- Issue date: 2014 Dec